CAS 34661-75-1
:Urapidil
Description:
Urapidil is a pharmaceutical compound primarily used as an antihypertensive agent. It functions as an alpha-1 adrenergic receptor antagonist and a partial agonist at serotonin receptors, which contributes to its blood pressure-lowering effects. Urapidil is characterized by its ability to reduce peripheral vascular resistance without significantly affecting heart rate, making it beneficial for treating hypertension, particularly in patients with heart failure or those at risk of cardiovascular events. The compound is typically administered orally or intravenously, depending on the clinical scenario. Its pharmacokinetics include rapid absorption and a relatively short half-life, necessitating careful dosing to maintain therapeutic effects. Urapidil is generally well-tolerated, but potential side effects may include dizziness, fatigue, and gastrointestinal disturbances. As with any medication, its use should be guided by a healthcare professional, considering individual patient factors and potential drug interactions. Overall, Urapidil represents a valuable option in the management of hypertension, particularly in specific patient populations.
Formula:C20H29N5O3
InChI:InChI=1S/C20H29N5O3/c1-22-18(15-19(26)23(2)20(22)27)21-9-6-10-24-11-13-25(14-12-24)16-7-4-5-8-17(16)28-3/h4-5,7-8,15,21H,6,9-14H2,1-3H3
InChI key:InChIKey=ICMGLRUYEQNHPF-UHFFFAOYSA-N
SMILES:O(C)C1=C(C=CC=C1)N2CCN(CCCNC=3N(C)C(=O)N(C)C(=O)C3)CC2
Synonyms:- 2,4(1H,3H)-Pyrimidinedione, 6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-
- 6-({3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl}amino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione
- 6-[[3-[4-(2-Methoxyphenyl)-1-Piperazinyl]Propyl]Amino]-1,3-Dimethyluracil
- 6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]-propyl]amino]1,3-dimethyl-2,4(1H,3H)-pyrimidinedione
- B 66256
- Ebrantil
- Eupressyl
- Mediatensyl
- NSC 310405
- Urapidil hcl
- Uraprene
- Uropidil
- Urapidil
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 15 products.
Urapidil
CAS:Formula:C20H29N5O3Purity:>95.0%(T)(HPLC)Color and Shape:White to Light yellow to Light orange powder to crystalMolecular weight:387.48Urapidil (6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione)
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormula:C20H29N5O3Color and Shape:PowderMolecular weight:387.227046-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione
CAS:Formula:C20H29N5O3Purity:98%Color and Shape:SolidMolecular weight:387.4760Urapidil
CAS:Formula:C20H29N5O3Purity:≥ 98.0%Color and Shape:White to off-white powderMolecular weight:387.48Urapidil
CAS:Urapidil (Ebrantil), a sympatholytic antihypertensive drug, acts as a 5-HT1A receptor agonist and as an α1-adrenoceptor antagonist.Formula:C20H29N5O3Purity:99.98% - >99.99%Color and Shape:SolidMolecular weight:387.48Urapidil
CAS:Urapidil is a vasodilator that acts by inhibiting the conversion of angiotensin I to angiotensin II. It is used mainly in the treatment of congestive heart failure and high blood pressure. Urapidil has been shown to increase the levels of natriuretic peptides such as atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), which are important for the regulation of blood volume. Urapidil has also been shown to decrease systolic pressure in humans, although it may have toxic effects on liver cells. Urapidil is not metabolized in humans, but is hydrolyzed by enzymes in laboratory animals.
Formula:C20H29N5O3Purity:Min. 95%Color and Shape:White PowderMolecular weight:387.48 g/mol
![6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione](https://static.cymitquimica.com/products/IN/thumb/DA007D5H.jpg)
